France-based company Capital B continues to increase its Bitcoin reserves! Here’s the latest purchase amount

French-based publicly traded company Capital B announced it has added another 192 Bitcoins to its portfolio, continuing its strategy of increasing Bitcoin reserves. According to the company’s official statement, this purchase cost approximately €13 million. With this latest acquisition, the company’s total Bitcoin holdings have risen to 3,135 BTC.

The statement indicated that the company’s return on Bitcoin investments since the beginning of the year has reached 1.82 percent. This performance once again demonstrates Capital B’s placement of digital assets at the heart of its long-term institutional reserve strategy. The company is among the leading publicly traded firms in Europe adopting the “Bitcoin treasury reserve” approach, which has become increasingly popular, particularly among institutional investors.

Capital B’s latest purchase coincides with a period in which the trend of institutional companies accumulating Bitcoin is gaining strength globally. In recent months, numerous companies, particularly in the US and Europe, have accelerated their Bitcoin purchases to diversify their balance sheets and hedge against inflation risk. Analysts say this trend further strengthens the place of digital assets in the traditional financial system.

The company management emphasized that they view Bitcoin as a long-term store of value and will continue their strategic accumulation model despite market fluctuations. This step taken by Capital B shows that institutional adoption is not limited to US-based companies but is gaining strong momentum in Europe as well.

Market experts say that increasing Bitcoin purchases by publicly traded companies could increase pressure on supply and have a supportive effect on the price in the long term. Capital B’s continued growth in its reserves is considered a significant development indicating continued confidence of institutional investors in Bitcoin.

*This is not investment advice.